Adane F. Wogu

469 total citations
18 papers, 279 citations indexed

About

Adane F. Wogu is a scholar working on Oncology, Obstetrics and Gynecology and Infectious Diseases. According to data from OpenAlex, Adane F. Wogu has authored 18 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Obstetrics and Gynecology and 4 papers in Infectious Diseases. Recurrent topics in Adane F. Wogu's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 Impact on Reproduction (4 papers). Adane F. Wogu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 Impact on Reproduction (4 papers). Adane F. Wogu collaborates with scholars based in United States and Malawi. Adane F. Wogu's co-authors include Gary H. Lyman, Marek S. Poniewierski, David C. Dale, Eva Culakova, Nicole M. Kuderer, Jeffrey Crawford, Ramya Thota, Mark Piegore, Kenneth G. Mann and Matthew F. Whelihan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Adane F. Wogu

17 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adane F. Wogu United States 8 100 65 51 45 30 18 279
Mukul Aggarwal India 9 57 0.6× 69 1.1× 80 1.6× 43 1.0× 17 0.6× 66 277
Ghada Elgohary Egypt 10 139 1.4× 71 1.1× 110 2.2× 36 0.8× 29 1.0× 31 298
Tuğçe Nur Yiğenoğlu Türkiye 9 147 1.5× 144 2.2× 73 1.4× 47 1.0× 29 1.0× 65 303
Giacomo Malipiero Italy 12 29 0.3× 73 1.1× 31 0.6× 34 0.8× 86 2.9× 18 406
Mehmet Sözen Türkiye 9 61 0.6× 62 1.0× 19 0.4× 23 0.5× 18 0.6× 41 271
Elifcan Aladağ Türkiye 9 46 0.5× 154 2.4× 148 2.9× 36 0.8× 18 0.6× 36 358
Ida Hed Myrberg Sweden 14 74 0.7× 90 1.4× 135 2.6× 32 0.7× 22 0.7× 35 454
Luca Cupelli Italy 13 187 1.9× 49 0.8× 147 2.9× 42 0.9× 111 3.7× 40 482
Sinem Namdaroğlu Türkiye 8 137 1.4× 131 2.0× 74 1.5× 26 0.6× 25 0.8× 30 252
Alper Özcan Türkiye 8 38 0.4× 33 0.5× 36 0.7× 22 0.5× 86 2.9× 63 314

Countries citing papers authored by Adane F. Wogu

Since Specialization
Citations

This map shows the geographic impact of Adane F. Wogu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adane F. Wogu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adane F. Wogu more than expected).

Fields of papers citing papers by Adane F. Wogu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adane F. Wogu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adane F. Wogu. The network helps show where Adane F. Wogu may publish in the future.

Co-authorship network of co-authors of Adane F. Wogu

This figure shows the co-authorship network connecting the top 25 collaborators of Adane F. Wogu. A scholar is included among the top collaborators of Adane F. Wogu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adane F. Wogu. Adane F. Wogu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Roberts, Samantha C., Sarah E. Jolley, Laurel Beaty, et al.. (2024). Association between monoclonal antibody therapy, vaccination, and longer‐term symptom resolution after acute COVID‐19. Journal of Medical Virology. 96(3). e29541–e29541.
2.
Wogu, Adane F., et al.. (2024). Psychometric Analysis of the Brøset Violence Checklist in Medical–Surgical Nursing Units. Nursing Forum. 2024(1). 1 indexed citations
3.
Wendel, Sarah K., Adane F. Wogu, Nichole E. Carlson, et al.. (2024). Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19. SHILAP Revista de lepidopterología. 5(1). e13116–e13116. 1 indexed citations
4.
Kaizer, Alexander, Hayley M. Belli, Samantha C. Roberts, et al.. (2023). Recent innovations in adaptive trial designs: A review of design opportunities in translational research. Journal of Clinical and Translational Science. 7(1). e125–e125. 21 indexed citations
5.
Wogu, Adane F., et al.. (2023). Additive Subdistribution Hazards Regression for Competing Risks Data in Case-Cohort Studies. Biometrics. 79(4). 3010–3022. 2 indexed citations
6.
Aggarwal, Neil R., Laurel Beaty, Tellen D. Bennett, et al.. (2022). Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. The Journal of Infectious Diseases. 226(12). 2129–2136. 36 indexed citations
7.
Douin, David J., Adane F. Wogu, Laurel Beaty, et al.. (2022). Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients. BMC Infectious Diseases. 22(1). 818–818. 2 indexed citations
8.
Wynia, Matthew K., Laurel Beaty, Tellen D. Bennett, et al.. (2022). Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients. CHEST Journal. 163(5). 1061–1070. 26 indexed citations
9.
Ataga, Kenneth I., Laila Elsherif, David Wichlan, et al.. (2021). A pilot study of the effect of rivaroxaban in sickle cell anemia. Transfusion. 61(6). 1694–1698. 3 indexed citations
10.
Wogu, Adane F., Shanshan Zhao, Hazel B. Nichols, & Jianwen Cai. (2021). Proportional Subdistribution Hazards Model for Competing Risks in Case-Cohort Studies. 9(5). 165–165. 1 indexed citations
11.
Elsherif, Laila, J. Brett Heimlich, Portia Kamthunzi, et al.. (2018). Exploratory Study of Urine Metabolomics in Sickle Cell Disease Children with Albuminuria in Malawi. Blood. 132(Supplement 1). 3680–3680. 1 indexed citations
12.
Whelihan, Matthew F., Ming Y. Lim, Micah J. Mooberry, et al.. (2016). Thrombin generation and cell‐dependent hypercoagulability in sickle cell disease. Journal of Thrombosis and Haemostasis. 14(10). 1941–1952. 55 indexed citations
13.
Peppercorn, Jeffrey, Kevin Houck, Nina Beri, et al.. (2015). Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance. Breast Cancer Research and Treatment. 153(3). 659–667. 15 indexed citations
14.
Wogu, Adane F., Christopher A. Loffredo, Ionut Bebu, & George Luta. (2014). Mediation analysis of gestational age, congenital heart defects, and infant birth-weight. BMC Research Notes. 7(1). 926–926. 8 indexed citations
15.
Culakova, Eva, Ramya Thota, Marek S. Poniewierski, et al.. (2014). Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study. Cancer Medicine. 3(2). 434–444. 83 indexed citations
16.
Peppercorn, Jeffrey, Kevin Houck, Adane F. Wogu, et al.. (2013). National survey of breast cancer screening in rural America.. Journal of Clinical Oncology. 31(26_suppl). 13–13. 4 indexed citations
17.
Shayne, Michelle, Eva Culakova, Marek S. Poniewierski, et al.. (2013). Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. Journal of Geriatric Oncology. 4(4). 310–318. 18 indexed citations
18.
Lyman, Gary H., Marek S. Poniewierski, Adane F. Wogu, et al.. (2013). Association of survival with chemotherapy intensity, myelosuppression, and supportive care in patients with advanced solid tumors.. Journal of Clinical Oncology. 31(15_suppl). 6534–6534. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mukul Aggarwal Breakdown of academic impact, for papers by Ghada Elgohary Breakdown of academic impact, for papers by Tuğçe Nur Yiğenoğlu Breakdown of academic impact, for papers by Giacomo Malipiero Breakdown of academic impact, for papers by Mehmet Sözen Breakdown of academic impact, for papers by Elifcan Aladağ Breakdown of academic impact, for papers by Ida Hed Myrberg Breakdown of academic impact, for papers by Luca Cupelli Breakdown of academic impact, for papers by Sinem Namdaroğlu Breakdown of academic impact, for papers by Alper Özcan
Rankless by CCL
2026